Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.

Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q34020978
Tenfibgen ligand nanoencapsulation delivers bi-functional anti-CK2 RNAi oligomer to key sites for prostate cancer targeting using human xenograft tumors in micePreclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapyTenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.Casein kinases as potential therapeutic targets.Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer.Evaluation of NIN/RPN12 binding protein inhibits proliferation and growth in human renal cancer cells.Cats, Cancer and Comparative OncologySimultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme.
P2860

Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q34020978
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mechanism and efficacy of sub- ...... tatic squamous cell carcinoma.
@ast
Mechanism and efficacy of sub- ...... tatic squamous cell carcinoma.
@en
Mechanism and efficacy of sub- ...... tatic squamous cell carcinoma.
@nl
type
label
Mechanism and efficacy of sub- ...... tatic squamous cell carcinoma.
@ast
Mechanism and efficacy of sub- ...... tatic squamous cell carcinoma.
@en
Mechanism and efficacy of sub- ...... tatic squamous cell carcinoma.
@nl
prefLabel
Mechanism and efficacy of sub- ...... tatic squamous cell carcinoma.
@ast
Mechanism and efficacy of sub- ...... tatic squamous cell carcinoma.
@en
Mechanism and efficacy of sub- ...... tatic squamous cell carcinoma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Mechanism and efficacy of sub- ...... static squamous cell carcinoma
@en
P2093
P2860
P304
P31
P356
10.1158/1535-7163.MCT-14-0166
P433
P478
P50
P577
P5875
P698
P932